Patents Assigned to Panmira Pharmaceuticals, Inc.
  • 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
    Publication number: 20130102636
    Abstract: A method for treating a human comprises administering a therapeutically effective amount of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid or a pharmaceutically acceptable salt or a pharmaceutically acceptable N-oxide thereof, to the human in need.
    Type: Application
    Filed: October 30, 2012
    Publication date: April 25, 2013
    Applicant: Panmira Pharmaceuticals, Inc.
    Inventor: Panmira Pharmaceuticals, Inc.
  • -disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
    Patent number: 8168678
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Grant
    Filed: January 29, 2009
    Date of Patent: May 1, 2012
    Assignee: Panmira Pharmaceuticals, Inc.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Yen Pham Truong